Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agnès Bellanger

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
La Revue Du Praticien|December 5, 2018
Véronique Leblond, Agnès Bellanger
La Revue Du Praticien|December 5, 2018
Véronique Leblond, Agnès Bellanger
Bulletin Du Cancer|April 19, 2012
[Monitoring and evaluation tools for irinotecan and bevacizumab in glioblastoma: from prescription to patient's information]Yasmine Hassani, Caroline Hochart, Lamia Hassani, et al.
European Journal of Hospital Pharmacy : Science and Practice|May 19, 2020
Management of diabetic foot ulcers: a 25% lidocaine topical cream formulation design, physicochemical and microbiological assessmentsHassane Sadou Yayé, Antoine Faucheron, Léa Dupont, et al.
The Annals of Pharmacotherapy|February 6, 2009
Stability of oxaliplatin solutionAudrey Junker, Sandrine Roy, Marie-Catherine Desroches, et al.
Multiple Sclerosis and Related Disorders|March 20, 2015
High doses of biotin in chronic progressive multiple sclerosis: a pilot studyFrédéric Sedel, Caroline Papeix, Agnès Bellanger, et al.
British Journal of Haematology|December 5, 2019
Postallogeneic transplantation progressive multifocal leukoencephalopathy successfully treated by nivolumabMadalina Uzunov, Sophie Demeret, Stéphanie Nguyen-Quoc, et al.
International Archives of Occupational and Environmental Health|April 29, 2021
Correction to: Effectiveness of cleaning of workplace cytotoxic surfaceLaetitia Minh Mai Lê, Pierre Alain Jolivot, Hassane Sadou Yayé, et al.
International Archives of Occupational and Environmental Health|April 25, 2012
Effectiveness of cleaning of workplace cytotoxic surfaceLaetitia Minh Mai Lê, Pierre Alain Jolivot, Hassane Sadou Yaye, et al.
Archives of Neurology|January 13, 2010
Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutationsRabab Debs, Christel Depienne, Agnès Rastetter, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
La Revue Du Praticien|December 5, 2018
Véronique Leblond, Agnès Bellanger
La Revue Du Praticien|December 5, 2018
Véronique Leblond, Agnès Bellanger
Bulletin Du Cancer|April 19, 2012
[Monitoring and evaluation tools for irinotecan and bevacizumab in glioblastoma: from prescription to patient's information]Yasmine Hassani, Caroline Hochart, Lamia Hassani, et al.
European Journal of Hospital Pharmacy : Science and Practice|May 19, 2020
Management of diabetic foot ulcers: a 25% lidocaine topical cream formulation design, physicochemical and microbiological assessmentsHassane Sadou Yayé, Antoine Faucheron, Léa Dupont, et al.
The Annals of Pharmacotherapy|February 6, 2009
Stability of oxaliplatin solutionAudrey Junker, Sandrine Roy, Marie-Catherine Desroches, et al.
Multiple Sclerosis and Related Disorders|March 20, 2015
High doses of biotin in chronic progressive multiple sclerosis: a pilot studyFrédéric Sedel, Caroline Papeix, Agnès Bellanger, et al.
British Journal of Haematology|December 5, 2019
Postallogeneic transplantation progressive multifocal leukoencephalopathy successfully treated by nivolumabMadalina Uzunov, Sophie Demeret, Stéphanie Nguyen-Quoc, et al.
International Archives of Occupational and Environmental Health|April 29, 2021
Correction to: Effectiveness of cleaning of workplace cytotoxic surfaceLaetitia Minh Mai Lê, Pierre Alain Jolivot, Hassane Sadou Yayé, et al.
International Archives of Occupational and Environmental Health|April 25, 2012
Effectiveness of cleaning of workplace cytotoxic surfaceLaetitia Minh Mai Lê, Pierre Alain Jolivot, Hassane Sadou Yaye, et al.
Archives of Neurology|January 13, 2010
Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutationsRabab Debs, Christel Depienne, Agnès Rastetter, et al.
Pageof 2